Predictors of health functioning in two high-risk groups of smokers
The relative and combined health effects of cigarette smoking, heroin use, and depression were examined in 322 clinically depressed smokers and 117 opioid-dependent smokers participating in two studies of the San Francisco Treatment Research Center. Opioid-dependent smokers averaged 16 years (S.D. =...
Gespeichert in:
Veröffentlicht in: | Drug and alcohol dependence 2005-05, Vol.78 (2), p.169-175 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The relative and combined health effects of cigarette smoking, heroin use, and depression were examined in 322 clinically depressed smokers and 117 opioid-dependent smokers participating in two studies of the San Francisco Treatment Research Center. Opioid-dependent smokers averaged 16 years (S.D.
=
9) of heroin use; 3% of depressed smokers used opiates in the past 6 months. Cigarettes per day (
M
=
15, S.D.
=
10) and Beck Depression (BDI-II) scores (
M
=
21, S.D.
=
11) were comparable between the two groups. Health functioning was assessed using the
Medical Outcomes Study Short Form (
SF-36). Adjusting for demographic differences, depressed smokers reported better physical but poorer emotional health relative to opioid-dependent smokers. Both groups scored significantly lower than published norms (
p
<
.05). Within groups, severity of depressive symptoms, tobacco use, and opiate use were independent predictors of lower health functioning (
p
<
.05). Examining risk-related subgroups based on depression scores (BDI-II
≥
20), cigarettes per day (≥1 pack), and opiate use, number of risk factors was monotonically related to health functioning in both samples. Individuals with two or more risk factors scored the lowest (
p
<
.05). Severity of depressive symptoms, tobacco use, and opiate use contributed individually and collectively to lower health functioning. Blended treatments that target multiple risk factors are needed to improve health outcomes. |
---|---|
ISSN: | 0376-8716 1879-0046 |
DOI: | 10.1016/j.drugalcdep.2004.10.012 |